Elevated amygdala metabolic activity on pre-treatment ¹8F-FDG PET/CT, a surrogate marker of chronic stress, was independently associated with distant metastasis in CRC. AmygA might serve as a novel imaging biomarker for risk stratification and offer insight into stress-related neural mechanisms underlying metastatic progression.
Kim et al. (Tue,) studied this question.